Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice

Core Viewpoint - C4 Therapeutics, Inc. (CCCC) is identified as a promising momentum stock with a Momentum Style Score of A and a Zacks Rank of 2 (Buy) [2][3][11] Price Performance - CCCC shares have increased by 25% over the past week, significantly outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 1.38% during the same period [5] - Over the last month, CCCC's price change is 77.19%, compared to the industry's 0.91% [5] - In the last quarter, CCCC shares rose by 19.29%, and over the past year, they gained 28.39%, while the S&P 500 experienced a decline of -0.32% in the last quarter and a gain of 18.16% over the past year [6] Trading Volume - The average 20-day trading volume for CCCC is 2,449,020 shares, indicating a bullish sign as the stock is rising with above-average volume [7] Earnings Outlook - In the past two months, two earnings estimates for CCCC have been revised upward, while none have been revised downward, leading to an increase in the consensus estimate from -$1.22 to -$1.02 [9] - For the next fiscal year, one estimate has moved upwards with no downward revisions during the same period [9]